Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 348

1.

Plant-topsoil relationships underlying subalpine grassland patchiness.

Armas-Herrera CM, Badía-Villas D, Mora JL, Gómez D.

Sci Total Environ. 2019 Oct 4:134483. doi: 10.1016/j.scitotenv.2019.134483. [Epub ahead of print]

PMID:
31822420
2.

Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

Shaverdian N, Offin MD, Rimner A, Shepherd AF, Wu AJ, Rudin CM, Hellmann MD, Chaft JE, Gomez DR.

Radiother Oncol. 2019 Nov 28;144:101-104. doi: 10.1016/j.radonc.2019.11.015. [Epub ahead of print]

PMID:
31786421
3.

A Tunable Polymer-Metal Based Anti-Reflective Metasurface.

Brasse Y, Ng C, Magnozzi M, Zhang H, Mulvaney P, Fery A, Gómez DE.

Macromol Rapid Commun. 2020 Jan;41(1):e1900415. doi: 10.1002/marc.201900415. Epub 2019 Nov 29.

PMID:
31782585
4.

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC.

Lin SH, Lin Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Simon G, Skoulidis F, Chang JY, Jeter MD, Liao Z, Gomez DR, O'Reilly M, Papadimitrakopoulou V, Thall P, Heymach JV, Tsao AS.

J Thorac Oncol. 2019 Nov 25. pii: S1556-0864(19)33659-7. doi: 10.1016/j.jtho.2019.10.024. [Epub ahead of print]

PMID:
31778797
5.

Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer.

Moreno AC, Zhang N, Giordano SH, Liao Z, Gomez D, Chang JY, Lin SH.

Int J Part Ther. 2018 Fall;5(2):18-27. doi: 10.14338/IJPT/18-00029.1. Epub 2018 Nov 30.

6.

Response to Letter to Editor from Fodor et al., "The 'Radical' Palliation That Increases Survival in Malignant Pleural Mesothelioma".

Gomez DR, Rimner A.

J Thorac Oncol. 2019 Dec;14(12):e284-e285. doi: 10.1016/j.jtho.2019.09.199. No abstract available.

PMID:
31757385
7.

Self-assembly of spherical and rod-shaped nanoparticles with full positional control.

Lloyd JA, Liu Y, Ng SH, Thai T, Gómez DE, Widmer-Cooper A, Bach U.

Nanoscale. 2019 Dec 21;11(47):22841-22848. doi: 10.1039/c9nr06679a. Epub 2019 Nov 22.

PMID:
31755510
8.

Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial.

Tang C, Lee WC, Reuben A, Chang L, Tran H, Little L, Gumbs C, Wargo J, Futreal A, Liao Z, Xia X, Yi X, Swisher SG, Heymach JV, Gomez D, Zhang J.

Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):349-357. doi: 10.1016/j.ijrobp.2019.10.038. Epub 2019 Oct 31.

9.

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion.

Dwivedi OP, Lehtovirta M, Hastoy B, Chandra V, Krentz NAJ, Kleiner S, Jain D, Richard AM, Abaitua F, Beer NL, Grotz A, Prasad RB, Hansson O, Ahlqvist E, Krus U, Artner I, Suoranta A, Gomez D, Baras A, Champon B, Payne AJ, Moralli D, Thomsen SK, Kramer P, Spiliotis I, Ramracheya R, Chabosseau P, Theodoulou A, Cheung R, van de Bunt M, Flannick J, Trombetta M, Bonora E, Wolheim CB, Sarelin L, Bonadonna RC, Rorsman P, Davies B, Brosnan J, McCarthy MI, Otonkoski T, Lagerstedt JO, Rutter GA, Gromada J, Gloyn AL, Tuomi T, Groop L.

Nat Genet. 2019 Nov;51(11):1596-1606. doi: 10.1038/s41588-019-0513-9. Epub 2019 Nov 1.

PMID:
31676859
10.

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.

Welsh JW, Tang C, de Groot P, Naing A, Hess KR, Heymach JV, Papadimitrakopoulou VA, Cushman TR, Subbiah V, Chang JY, Simon GR, Ramapriyan R, Barsoumian HB, Menon H, Cortez MA, Massarelli E, Nguyen Q, Sharma P, Allison JP, Diab A, Verma V, Raju U, Shaaban SG, Dadu R, Cabanillas ME, Wang K, Anderson C, Gomez DR, Hahn S, Komaki R, Hong DS.

Cancer Immunol Res. 2019 Dec;7(12):1903-1909. doi: 10.1158/2326-6066.CIR-18-0793. Epub 2019 Oct 28.

PMID:
31658994
11.

The Tandem Photoredox Catalysis Mechanism of [Ir(ppy)2(dtb-bpy)]+ Enabling Access to Energy Demanding Organic Substrates.

Connell TU, Fraser CL, Czyz ML, Smith ZM, Hayne DJ, Doeven EH, Agugiaro J, Wilson DJD, Adcock JL, Scully AD, Gómez DE, Barnett NW, Polyzos A, Francis PS.

J Am Chem Soc. 2019 Nov 6;141(44):17646-17658. doi: 10.1021/jacs.9b07370. Epub 2019 Oct 24.

PMID:
31545022
12.

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW.

JAMA Oncol. 2019 Sep 17. doi: 10.1001/jamaoncol.2019.2809. [Epub ahead of print]

PMID:
31529018
13.

2D Freestanding Janus Gold Nanocrystal Superlattices.

Shi Q, Gómez DE, Dong D, Sikdar D, Fu R, Liu Y, Zhao Y, Smilgies DM, Cheng W.

Adv Mater. 2019 Sep;31(37):e1904636. doi: 10.1002/adma.201904636. No abstract available.

PMID:
31503376
14.

Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC.

Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH.

J Thorac Oncol. 2020 Jan;15(1):101-109. doi: 10.1016/j.jtho.2019.08.2505. Epub 2019 Aug 31.

PMID:
31479748
15.

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK.

J Thorac Oncol. 2019 Oct;14(10):1718-1731. doi: 10.1016/j.jtho.2019.08.012. Epub 2019 Aug 27.

PMID:
31470129
16.

Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.

Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB.

Clin Lung Cancer. 2020 Jan;21(1):37-46.e7. doi: 10.1016/j.cllc.2019.07.007. Epub 2019 Aug 1.

PMID:
31447303
17.

Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.

Nelson DB, Rice DC, Mitchell KG, Tsao AS, Gomez DR, Sepesi B, Mehran RJ.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):924-929. doi: 10.1016/j.jtcvs.2019.02.129. Epub 2019 Apr 16.

PMID:
31430846
18.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2019 Jul 27. pii: djz154. doi: 10.1093/jnci/djz154. [Epub ahead of print]

PMID:
31350545
19.

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.

Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, Nowak A, Peikert T, Salgia R, Szlosarek P, Taioli E, Yang H, Tsao A, Mansfield AS.

J Thorac Oncol. 2019 Oct;14(10):1704-1717. doi: 10.1016/j.jtho.2019.06.020. Epub 2019 Jun 28.

PMID:
31260832
20.

Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.

Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B.

J Thorac Dis. 2019 Apr;11(4):1269-1278. doi: 10.21037/jtd.2019.04.27.

Supplemental Content

Loading ...
Support Center